NDC 50419-540 – Kerendia

Finerenone 10 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC50419-540

Product details

Brand name
Kerendia
Generic name
Finerenone
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA215341
Marketed since
July 9, 2021
Listing expires
December 31, 2026
Pharmacologic class
Nonsteroidal Mineralocorticoid-Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Kerendia →

Package NDC codes (4)

Package NDCDescriptionSince
50419-540-0130 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-01)Jul 9, 2021
50419-540-0290 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-02)Jul 9, 2021
50419-540-0610 TABLET, FILM COATED in 1 BLISTER PACK (50419-540-06)Aug 23, 2025
50419-540-707 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-70)Jul 9, 2021

Other Kerendia products